WST
West Pharmaceutical Services Inc
370.40$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.9% | 15.2% | 14.5% | 16.5% | 16.8% | 19.9% | 22.0% | 20.6% | 25.1% | 26.3% | 22.6% | 24.6% | |
| 6.3% | 6.4% | 6.0% | 6.0% | 6.1% | 5.6% | 5.1% | 4.3% | 4.2% | 4.7% | 5.4% | 5.5% | |
| 1.3% | 2.1% | 1.3% | 1.0% | 0.9% | 1.3% | 1.6% | 1.3% | 0.8% | 0.8% | 0.6% | 0.8% | |
| -0.3% | 4.8% | 2.2% | 4.0% | 0.7% | 2.0% | 1.1% | -0.7% | 1.0% | – | – | – | |
| -2.2% | -0.8% | -3.9% | -2.6% | -1.6% | -0.8% | -0.5% | -6.8% | -0.4% | -0.7% | 0.1% | 2.6% | |
| 7.9% | 9.4% | 11.3% | 8.2% | 6.1% | 6.9% | 8.1% | 9.0% | 9.9% | 12.3% | 13.0% | 9.3% | |
| -7.3% | -9.3% | -11.6% | -8.4% | -5.9% | -12.4% | -8.4% | -8.9% | -10.0% | -12.5% | -13.1% | -9.3% | |
| 2.0% | 2.3% | 2.4% | 2.4% | 2.5% | 2.4% | 2.2% | 1.8% | 1.9% | 1.9% | 2.0% | 2.0% | |
| -0.3% | -0.4% | -3.7% | -4.7% | -4.1% | -4.5% | -5.4% | -5.4% | -7.7% | -15.3% | -19.6% | -4.4% | |
| -1.6% | -2.0% | -4.6% | -2.2% | 0.0% | 3.3% | -0.1% | -0.1% | -1.6% | -0.1% | -1.0% | 0.0% | |
| -2.2% | -3.0% | -7.5% | -6.8% | -4.7% | -2.0% | -6.4% | -5.9% | -10.2% | -15.6% | -21.5% | -6.0% | |
| 1.8% | 1.4% | -4.7% | 2.1% | 5.9% | 5.5% | 8.2% | 5.2% | 4.6% | -1.4% | -12.8% | 10.0% | |
| 5.0% | 5.8% | 3.3% | 8.3% | 10.7% | 13.1% | 13.9% | 11.7% | 15.2% | 14.0% | 9.6% | 15.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.